COVID-19 and reactions in the Norwegian population

Publications 2022

Burnier M, Kjeldsen SE, Narkiewicz K, Egan B, Kreutz R (2022)
Hypertension management during the COVID-19 pandemic: what can we learn for the future?
Blood Press, 31 (1), 47-49
DOI 10.1080/08037051.2022.2058909, PubMed 35426323

Meroni PL, Croci S, Lonati PA, Pregnolato F, Spaggiari L, Besutti G, Bonacini M, Ferrigno I, Rossi A, Hetland G, Hollan I, Cugno M, Tedesco F, Borghi MO, Salvarani C (2022)
Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients
Autoimmun Rev, 103232 (in press)
DOI 10.1016/j.autrev.2022.103232, PubMed 36414219

Bjørlykke KH, Ørbo HS, Tveter AT, Jyssum I, Sexton J, Tran TT, Christensen IE, Kro GB, Kvien TK, Jahnsen J, Munthe LA, Chopra A, Warren DJ, Mjaaland S, Haavardsholm EA, Grødeland G, Provan SA, Vaage JT, Syversen SW, Goll GL, Jørgensen KK (2022)
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
Lancet Rheumatol (in press)
DOI 10.1016/S2665-9913(22)00330-7, PubMed 36415604